does medicare cover glp-1 drugs expands access to weight loss Temps may rise, but your
Description
Your workforce likely has a growing interest (or curiosity) in GLP-1 medications
IL-6 mirrored the time course of GLP-2
Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication
New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.
Individuals interested in supporting gut microbiome balance and metabolic wellness may consider targeted probiotic supplements
